TRANSDERMAL LIMITED - Profile & Financials

CompanyTrack

Previous Company Names

STOWPHARM LIMITED 10 Nov 1993 — 22 May 1995

CHELTRADING 61 LIMITED 20 Oct 1993 — 10 Nov 1993

Accounts Submitted 27 Mar 2024

Confirmation Not Submitted

Net assets £729K £290K 2023 year on year

Total assets £904K £166K 2023 year on year

Total Liabilities £175K £124K 2023 year on year

Charges None No charges registered

Contact & Details

Contact

Registered Address

Suite G 19 The Business & Technology Centre Bessemer Drive Stevenage SG1 2DX England

Full company profile for TRANSDERMAL LIMITED (02865010), a dissolved company based in Stevenage, England. Incorporated 20 Oct 1993. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Period 1 Jan → 31 Dec 2023

Type small

Next accounts —

Due by —

Net Assets, Total Assets & Total Liabilities (2015–2023)

Cash in Bank

£298.25k

Decreased by £589.29k (-66%)

Net Assets

£729.21k

Decreased by £289.84k (-28%)

Total Liabilities

£174.68k

Increased by £123.96k (+244%)

Turnover

N/A

Employees

N/A

Decreased by 2 (-100%)

Debt Ratio

19%

Increased by 14 (+280%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2023 31 Dec Year End	2022 31 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

0 active 3 resigned

Show resigned officers

						Status
No officers found

No officers found

Shareholders

Shareholders (1)


Parapharm Development Limited	100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased

Parapharm Development Limited

United Kingdom

Active

Notified 23 Oct 2017

Nature of Control

Ownership Of Shares 75 To 100 Percent

Anant Kumar Pandya

Ceased 23 Oct 2017

Ceased

Darshna Pandya

Ceased 23 Oct 2017

Ceased

Group Structure

NORDIC PHARMA LIMITED united kingdom

PARAPHARM DEVELOPMENT LIMITED united kingdom

TRANSDERMAL LIMITED Current Company

Charges

No charges registered

Properties

0 total

No related properties

Documents

Company Filings

Date	Category	Description
25 Feb 2025	Gazette	Gazette Dissolved Voluntary
13 Aug 2024	Dissolution	Dissolution Voluntary Strike Off Suspended
9 Aug 2024	Address	Change Registered Office Address Company With Date Old Address New Address
25 Jun 2024	Gazette	Gazette Notice Voluntary
14 Jun 2024	Dissolution	Dissolution Application Strike Off Company

25 Feb 2025 Gazette

Gazette Dissolved Voluntary

13 Aug 2024 Dissolution

Dissolution Voluntary Strike Off Suspended

9 Aug 2024 Address

Change Registered Office Address Company With Date Old Address New Address

25 Jun 2024 Gazette

Gazette Notice Voluntary

14 Jun 2024 Dissolution

Dissolution Application Strike Off Company

Recent Activity

Latest Activity

Gazette Dissolved Voluntary

1 years ago on 25 Feb 2025

Dissolution Voluntary Strike Off Suspended

1 years ago on 13 Aug 2024

Change Registered Office Address Company With Date Old Address New Address

1 years ago on 9 Aug 2024

Gazette Notice Voluntary

2 years ago on 25 Jun 2024

Dissolution Application Strike Off Company

2 years ago on 14 Jun 2024